369-26-6

Basic information

• Product Name: METHYL 3-AMINO-4-FLUOROBENZENECARBOXYLATE
• Synonyms: METHYL 3-AMINO-4-FLUOROBENZENECARBOXYLATE;Methyl 3-amino-4-fluorobenzoate;Methyl 3-amino-4-fluorobenzoate 99%;methyl 3-amino-4-fluorobenzoate(SALTDATA: HCl 0.7H2O);2-Fluoro-5-(methoxycarbonyl)aniline
• CAS NO: 369-26-6
• Molecular Formula: C₈H₈FNO₂
• Molecular Weight: 169.1530232
• Mol File: 369-26-6.mol
• Article Data: 11

Chemical Properties

• Melting Point: 66-69
• Boiling Point: 271.074 °C at 760 mmHg
• Flash Point: 117.742 °C
• Appearance: /
• Density: 1.264 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: METHYL 3-AMINO-4-FLUOROBENZENECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3-AMINO-4-FLUOROBENZENECARBOXYLATE(369-26-6)
• EPA Substance Registry System: METHYL 3-AMINO-4-FLUOROBENZENECARBOXYLATE(369-26-6)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 369-26-6(Hazardous Substances Data)

Usage

General Description

Methyl 3-amino-4-fluorobenzenecarboxylate is a chemical compound with the molecular formula C9H8FNO2. It is an aromatic ester with a methyl group attached to the carboxylate functional group. METHYL 3-AMINO-4-FLUOROBENZENECARBOXYLATE contains an amino group and a fluorine atom attached to the benzene ring, making it a potentially useful building block for the synthesis of pharmaceuticals and agrochemicals. It is also commonly used as an intermediate in the manufacture of various organic compounds, including dyes, pigments, and other specialty chemicals. Methyl 3-amino-4-fluorobenzenecarboxylate may have various industrial applications and is important for scientific research and development in the field of organic chemistry.

Upstream product

• 125568-76-5 methyl 3-azido-4-fluorobenzoate 
• 108-88-3 toluene 
• 400-94-2 4-fluoro-3-nitrobenzoyl chloride 
• 82702-31-6 methyl 3-bromo-4-fluorobenzoate 
• 1007-16-5 3-bromo-4-fluorobenzoic acid 
• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 67-56-1 methanol 
• 99-05-8 meta-aminobenzoic acid 
• 456-22-4 4-Fluorobenzoic acid 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 

Downstream Products

• 1426653-18-0 N-(5-(((1S,2S)-1,3-dihydroxy-1-phenylpropan-2-yl)carbamoyl)-2-fluorophenyl)imidazo[1,2-a]pyridine-3-carboxamide 
• 1426653-21-5 N-(2-fluoro-5-(((1S,2S)-1-hydroxy-3-methoxy-1-phenylpropan-2-yl)carbamoyl)phenyl)-7-methylimidazo[1,2-a]pyridine-3-carboxamide 
• 1426653-22-6 N-(5-(((1S,2S)-1,3-dihydroxy-1-phenylpropan-2-yl)carbamoyl)-2-fluorophenyl)-7-methylimidazo[1,2-a]pyridine-3-carboxamide 
• 1426653-25-9 7-(2-methyl-2H-pyrazol-3-yl)-imidazo[1,2-a]pyridine-3-carboxylic acid [2-fluoro-5-((1R,2R)-2-hydroxy-1-hydroxymethyl-2-phenyl-ethylcarbamoyl)-phenyl]-amide 
• 1426531-85-2 4-fluoro-3-(imidazo[1,2-a]pyridine-3-carboxamido)benzoic acid 
• 1426654-02-5 4-fluoro-3-(7-methylimidazo[1,2-a]pyridine-3-carboxamido)benzoic acid 
• 1426530-94-0 4-fluoro-3-{[7-(2-methyl-2H-pyrazol-3-yl)-imidazo[1,2-a]pyridine-3-carbonyl]-amino}-benzoic acid 
• 1426654-03-6 methyl 4-fluoro-3-(7-methylimidazo[1,2-a]pyridine-3-carboxamido)benzoate 
• 1426530-70-2 3-[(7-bromo-imidazo[1,2-a]pyridine-3-carbonyl)-amino]-4-fluoro-benzoic acid methyl ester 
• 1426531-86-3 methyl 4-fluoro-3-(imidazo[1,2-a]pyridine-3-carboxamido)benzoate 
• 1195765-71-9 N-{5-[5-(2-Amino-4-pyrimidinyl)-2-(1-methylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-3-fluorobenzenesulfonamide 
• 1422828-33-8 C₁₈H₁₂ClF₂N₃O₃S 
• 1195769-08-4 N-{5-[5-(2-chloro-4-pyrimidinyl)-2-(1-methylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-3-fluorobenzenesulfonamide 
• 1195764-74-9 2,6-Difluoro-N-{2-fluoro-5-[2-(1-methylethyl)-5-(2-{[2-(methylsulfonyl)ethyl]amino}-4-pyrimidinyl)-1,3-thiazol-4-yl]phenyl}benzenesulfonamide 

Relevant articles and documents

Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells

The biological function of the natural ent-kaurene diterpenoid isolated from genus Isodon, oridonin, has been intensively studied. However, its mechanism studies and clinical applications were hampered by its moderate biological activities. In order to en

FUSED BICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE

Fused bicyclic compounds and uses thereof in medicine. In particular, provided are fused bicyclic compounds used as ASK1 active regulator and and use of the compounds in the manufacture of a drug for treating a disease regulated by ASK1. Further provided are a pharmaceutical composition and a method of treating a disease regulated by ASK1 comprising administering the compounds or pharmaceutical composition thereof.

COMPOUNDS AND COMPOSITIONS AS PDGFR KINASE INHIBITORS

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase